Reduction in Chemotherapy Mixing Errors Using Six Sigma: Illinois CancerCare Experience.

Area of Science:

• Oncology
• Quality Improvement
• Healthcare Management

Background:

• Chemotherapy mixing errors (CTMRs) pose significant risks in oncology practice.
• Large cancer centers with multiple satellite locations face unique challenges in maintaining consistency.
• Standardization of processes is crucial for patient safety in chemotherapy administration.

Purpose of the Study:

• To implement and evaluate the effectiveness of Six Sigma methodology in reducing CTMRs.
• To improve the quality and safety of chemotherapy preparation and administration.
• To identify and address root causes of CTMRs within a large oncology practice.

Main Methods:

• A Six Sigma team, including nurses and pharmacy technicians, received DMAIC process training.
• Error data was collected through retrospective tracking, system audits, and staff surveys.
• Interventions included developing checklists, enhancing education, and implementing competency testing.

Main Results:

• The Six Sigma project reduced the CTMR rate from 0.050% to 0.019%, a 100-fold improvement (Sigma from 4.2 to 5.2).
• The proportion of errors affecting patients decreased from 77% to 15%.
• Annualized financial losses due to errors were reduced from $11,537.95 to $1,262.40.

Conclusions:

• Six Sigma is a highly effective methodology for reducing CTMRs in clinical practice.
• The implemented interventions successfully improved patient safety and operational efficiency.
• Continuous quality improvement processes are vital for minimizing medication errors in cancer care.